Klivira
Request demo

Streamline Emgality Prior Authorization with Klivira

Klivira automates the complex Emgality prior authorization process, reducing administrative burden and accelerating patient access to critical migraine and cluster headache therapies.

Managing prior authorizations for high-volume medications like Emgality presents significant challenges for revenue cycle teams. The intricate payer-specific requirements and manual processes often lead to delays, denials, and increased operational costs, directly impacting patient care and financial performance.

The Challenge of Emgality Prior Authorization

Emgality (galcanezumab) is a frequently prescribed CGRP inhibitor for migraine and cluster headache, but its high cost often places it under stringent prior authorization requirements across commercial, Medicare Advantage, and Medicaid managed care plans. These requirements vary significantly by payer, demanding meticulous attention to clinical criteria, step therapy protocols, and documentation.

Common Emgality Prior Authorization Requirements

  • Diagnosis of episodic or chronic migraine, or cluster headache, confirmed by medical records.
  • Documentation of previous failed trials of alternative prophylactic therapies (e.g., beta-blockers, antidepressants, anticonvulsants).
  • Specific frequency or severity of headache days per month.
  • Absence of contraindications or concurrent use of non-covered therapies.
  • Clinical notes supporting medical necessity and adherence to payer-specific criteria.

Klivira's Solution for Emgality PA Automation

Klivira leverages intelligent automation to navigate the complexities of Emgality prior authorization. Our platform integrates directly with your EMR system, extracting necessary patient data and automatically populating payer-specific forms. This eliminates manual data entry, reduces human error, and ensures complete submissions aligned with current payer requirements.

Seamless EMR Integration and Data Exchange

Our platform utilizes industry-standard protocols, including SMART on FHIR and X12 278, to facilitate secure and efficient data exchange between your EMR and payer portals. This robust integration ensures that clinical documentation, patient demographics, and authorization requests for Emgality are transferred accurately and in real-time, aligning with Da Vinci PAS implementation guides.

Navigating Payer-Specific Nuances for Emgality

Klivira maintains an up-to-date database of payer-specific rules and clinical criteria for Emgality across major commercial, Medicare Advantage, and Medicaid plans. Our system dynamically adjusts submission workflows to meet these varied requirements, proactively identifying potential gaps in documentation before submission to minimize denials and resubmissions.

Frequently asked questions

What are the most common reasons for Emgality prior authorization denials?

Denials for Emgality prior authorizations often stem from insufficient documentation of failed previous therapies, lack of adherence to specific headache frequency criteria, or administrative errors in submission. Klivira's system helps mitigate these by validating data against payer rules prior to submission.

How does Klivira integrate with our EMR for Emgality PA requests?

Klivira integrates with leading EMR systems via secure APIs, including SMART on FHIR. This allows for automated extraction of relevant patient data—such as diagnosis codes, medication history, and clinical notes—directly into the prior authorization workflow, streamlining the creation of Emgality PA requests.

Does Klivira handle appeals for Emgality prior authorization denials?

Klivira's platform supports the appeals process by organizing denial reasons and facilitating the submission of additional clinical documentation. While the clinical decision remains with your team, our system streamlines the administrative burden of preparing and submitting appeals for Emgality.

What data is typically required for an Emgality PA submission?

Typical data required includes patient demographics, NPI, ICD-10 codes for migraine or cluster headache, CPT codes for related services, NDC for Emgality, detailed clinical notes on diagnosis, prior failed therapies, headache frequency, and any contraindications.

Can Klivira help with Emgality prior authorizations for both new and existing patients?

Yes, Klivira is designed to manage Emgality prior authorizations for both initial requests for new patients and re-authorizations for existing patients. Our system tracks authorization expiry dates and proactively initiates renewal workflows to ensure continuous patient access.

Related coverage

Streamline prior authorization by payer

Streamline prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo